But in general, circulating biomarkers of insulin resistance and adipokines were at most weakly associated with CRC risk, and not clearly associated with specific subtypes of CRC based on KRAS- and BRAF-mutations and MSI status of the tumor. Here, BRAF is linked to Insulin resistance.